Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients

Background: Acting as a viral entry for coronavirus to invade human cells, TMPRSS2 has become a target for the prevention and treatment of COVID-19 infection. Before this, TMPRSS2 has presented biological functions in cancer, but the roles remain controversial and the mechanism remains unelucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Mei, Gao, Rui, Liu, Zixue, Liu, Fengxiang, Du, Shiyu, Song, Yizhi, He, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040610/
https://www.ncbi.nlm.nih.gov/pubmed/36992839
http://dx.doi.org/10.3389/fphar.2023.1085509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040610/
https://www.ncbi.nlm.nih.gov/pubmed/36992839
http://dx.doi.org/10.3389/fphar.2023.1085509

Ejemplares similares